induced lung injury (VILI) and ventilation-induced diaphragm dysfunction (VIDD), and more recently, VABI. [3][4][5]8,9 Thus, any new therapy intended to protect patients would also ideally mitigate VILI and VIDD, while mitigating VABI. Nevertheless, it is exciting to conceive of a future where ventilation strategies could be not only lung-protective, but also diaphragm-and brain-protective.Despite the many questions that remain to be answered, the investigation of VABI and its mitigation should always be encouraged and congratulated, improving the knowledge in this emerging field.